Knowles

US · KN #2417 by market cap Listed 1970

38.07 -1.12 -2.86%

Live - 5344 symbols - heartbeat 258s ago · 2026-10-08 02:18

After-hours 38.26 +0.49%

Overnight 37.98 -0.24%

Market cap: 3.25B
P/E (TTM): 50.09
P/B: 4.09
EPS: 0.50
Div yield: 0.00%
52W pos: 78%

Reader sentiment Are you bullish or bearish on KN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 7.33, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +7.17% YoY

Margins

Gross margin: 43.21%
Operating margin: 12.36%
Net margin: 7.45%

Key ratios & quality

Enterprise value: 3.32B
Altman Z-Score: 7.33

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	826.90M	854.80M	764.30M	868.10M	478.80M	456.80M	553.50M	593.20M
Gross profit	322.60M	328.00M	271.20M	359.50M	227.00M	203.80M	234.80M	256.30M
Selling & admin expenses	142.50M	145.70M	131.50M	146.40M	106.30M	125.80M	142.00M	142.80M
Research & development	100.60M	96.80M	92.90M	92.80M	29.30M	32.40M	39.50M	40.20M
Operating profit	79.50M	85.50M	46.80M	120.30M	91.40M	45.60M	53.30M	73.30M
Pretax profit	61.10M	66.30M	11.30M	104.60M	87.70M	37.30M	34.70M	64.00M
Tax	-4.50M	16.60M	8.40M	-45.60M	21.30M	-28.30M	11.30M	13.10M
Net profit	67.70M	49.10M	6.60M	150.40M	-430.10M	72.40M	-237.80M	44.20M
Basic EPS	1	1	0	2	-5	1	-3	1
Diluted EPS	0.74	0.53	0.07	1.59	-4.69	0.79	-2.67	0.50

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	132.20M	145.90M	152.90M	162.20M	153.10M	166.80M
Gross profit	53.30M	60.60M	69.90M	72.50M	67.10M	74.60M
Selling & admin expenses	37.20M	35.90M	34.00M	35.70M	39.40M	39.20M
Research & development	9.70M	10.00M	10.00M	10.50M	11.70M	10.60M
Operating profit	6.40M	14.70M	25.90M	26.30M	16.00M	24.80M
Pretax profit	800.00K	11.30M	22.30M	29.60M	11.00M	22.60M
Tax	1.20M	3.50M	4.30M	4.10M	-300.00K	4.20M
Net profit	-2.00M	7.80M	17.40M	21.00M	9.70M	19.40M
Basic EPS	0	0	0	0	0	0
Diluted EPS	-0.02	0.09	0.20	0.25	0.11	0.22

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	365.00M	388.40M	419.60M	380.30M	362.40M	428.80M	361.40M	291.40M
Cash & ST investments	73.50M	78.40M	147.80M	68.90M	48.20M	87.30M	130.10M	54.20M
Inventory	140.10M	141.80M	130.10M	153.10M	169.50M	127.00M	118.00M	124.60M
Total assets	1.55B	1.65B	1.65B	1.73B	1.18B	1.46B	1.12B	1.05B
Total current liabilities	141.80M	151.50M	297.30M	166.20M	99.10M	164.60M	197.60M	105.90M
Short-term debt	2.40M	11.70M	177.90M	14.10M	10.90M	53.80M	72.80M	5.40M
Long-term debt	158.10M	156.80M	--	70.00M	45.00M	224.10M	134.00M	114.00M
Total liabilities	336,300,000.00	366,100,000.00	351,400,000.00	272,100,000.00	191,000,000.00	428,700,000.00	362,200,000.00	275,300,000.00
Total equity	1.21B	1.29B	1.30B	1.46B	992.90M	1.03B	756.00M	775.80M
Retained earnings	-224.20M	-175.10M	-168.50M	-18.10M	-448.20M	-375.80M	-613.60M	-569.40M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	337.90M	334.80M	334.20M	291.40M	297.40M	324.30M
Cash & ST investments	101.90M	103.20M	92.50M	54.20M	41.00M	49.60M
Inventory	120.00M	119.70M	123.90M	124.60M	136.20M	147.10M
Total assets	1.10B	1.09B	1.09B	1.05B	1.05B	1.08B
Total current liabilities	167.60M	167.20M	176.00M	105.90M	90.90M	101.30M
Short-term debt	73.50M	74.70M	76.10M	5.40M	4.90M	4.50M
Long-term debt	119.00M	119.00M	104.00M	114.00M	131.00M	131.00M
Total liabilities	341,300,000.00	342,200,000.00	336,400,000.00	275,300,000.00	273,700,000.00	280,500,000.00
Total equity	755.80M	746.10M	751.80M	775.80M	780.20M	795.50M
Retained earnings	-615.60M	-607.80M	-590.40M	-569.40M	-559.70M	-540.30M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	98.50M	123.90M	128.10M	182.10M	86.30M	122.70M	130.10M	114.00M
Depreciation & amortization	52.40M	54.40M	60.60M	62.50M	53.90M	46.50M	50.30M	36.30M
Free cash flow	18.40M	82.70M	96.20M	133.50M	54.20M	105.80M	116.50M	81.90M
Dividends paid	--	--	--	--	--	--	--	--
Stock buybacks / issuance	0	0	-16.20M	-44.50M	-44.00M	-47.50M	-53.70M	-65.00M
Ending cash balance	73.50M	78.40M	147.80M	68.90M	48.20M	87.30M	130.10M	54.20M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	1.30M	36.40M	29.10M	47.20M	-700.00K	28.20M
Depreciation & amortization	9.00M	9.10M	9.00M	9.20M	9.20M	9.70M
Free cash flow	-2.70M	31.30M	21.40M	31.90M	-11.50M	21.70M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	-5.00M	-30.00M	-20.00M	-10.00M	-7.50M	-15.00M
Ending cash balance	101.90M	103.20M	92.50M	54.20M	41.00M	49.60M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	5.78	3.93	0.51	10.89	-35.08	7.14	-26.57	5.77
ROA %	4.37	3.07	0.40	8.88	-29.50	5.47	-18.43	4.08
ROIC %	5.83	4.18	1.24	10.48	-32.61	6.45	-19.81	5.49
5-year avg ROE %	-3.69	-1.79	2.48	5.50	-2.80	-2.52	-8.62	-7.57
EBIT margin %	9.40	9.55	3.72	13.71	-54.13	7.41	9.90	12.98
FCF / sales %	2.23	9.67	12.59	15.38	7.09	14.95	21.05	13.81
Current ratio	2.57	2.56	1.41	2.29	3.66	2.61	1.83	2.75
Quick ratio	1.51	1.57	0.94	1.30	1.85	1.08	1.19	1.48
Debt / assets	11.02	12.12	12.21	5.91	5.45	19.60	19.05	12.92
LT debt / equity	13.88	14.65	1.86	6.05	5.40	22.52	18.55	16.81
Interest coverage	4.68	5.33	1.66	8.26	-96.26	7.08	2.73	5.92
Revenue CAGR (3Y) %	3.14	4.19	0.89	1.63	-17.57	-15.77	-13.93	7.40
Net income CAGR (3Y) %	--	--	-54.11	30.48	--	122.19	--	--
FCF CAGR (3Y) %	10.06	6.33	32.56	93.59	-13.14	3.22	-4.44	14.75

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	-27.08	3.31	5.45	5.77	7.28	8.76
ROA %	-18.78	2.19	3.69	4.08	5.20	6.24
ROIC %	-19.92	3.67	5.37	5.49	6.94	8.09
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	9.58	9.64	10.95	12.98	14.00	15.20
FCF / sales %	18.08	19.45	14.26	13.81	11.90	10.00
Current ratio	2.02	2.00	1.90	2.75	3.27	3.20
Quick ratio	1.25	1.22	1.14	1.48	1.65	1.64
Debt / assets	19.12	19.38	18.14	12.92	14.38	13.96
LT debt / equity	18.03	18.25	16.13	16.81	18.79	18.32
Interest coverage	2.88	3.33	4.27	5.92	7.29	8.77
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Precision Devices is the largest reported line at 58.93% of revenue, across 2 reported segments.
MedTech & Specialty Audio follows at 41.07%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Precision Devices58.93%

MedTech & Specialty Audio41.07%

Quote time 2026-10-08 02:18:41 · For reference only, not investment advice and not tailored to your situation.